Loading...
The University of Chicago Header Logo
Keywords
Last Name
Institution

Elaine M. Worcester

TitleProfessor
InstitutionUniversity of Chicago
DepartmentMedicine-Nephrology
AddressChicago IL 60637
vCardDownload vCard

    Collapse Overview 

    Collapse Biography 
    Collapse education and training
    University of Chicago, Chicago, IL06/1986Fellowship, Nephrology
    Loyola University, Maywood, IL06/1982Residency, Internal Medicine
    University of Illinois, Chicago, ILMD06/1979
    Augustana College, Rock Island, ILBS06/1974Biology

    Collapse Research 
    Collapse research activities and funding
    P01DK056788     (WORCESTER, ELAINE M)Aug 1, 2000 - Jul 31, 2022
    NIH
    Pathogenesis of Calcium Nephrolithiasis
    Role: Principal Investigator

    Collapse Bibliographic 
    Collapse selected publications
    Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Faculty can login to make corrections and additions.
    List All   |   Timeline
    1. Borofsky M, Handa RK, Evan AP, Williams JC, Bledsoe SB, Coe F, Worcester EM, Lingeman JE. In Vivo Renal Tubule pH in Stone Forming Human Kidneys. J Endourol. 2019 Nov 23. PMID: 31760802.
      View in: PubMed
    2. Menezes CJ, Worcester EM, Coe FL, Asplin J, Bergsland KJ, Ko B. Mechanisms for falling urine pH with age in stone formers. Am J Physiol Renal Physiol. 2019 Jul 01; 317(7):F65-F72. PMID: 31017011.
      View in: PubMed
    3. Borofsky MS, Williams JC, Dauw CA, Cohen A, Evan AC, Coe FL, Worcester E, Lingeman JE. Association Between Randall's Plaque Stone Anchors and Renal Papillary Pits. J Endourol. 2019 Apr; 33(4):337-342. PMID: 30793930.
      View in: PubMed
    4. Evan AP, Coe FL, Lingeman J, Bledsoe S, Worcester EM. Randall's plaque in stone formers originates in ascending thin limbs. Am J Physiol Renal Physiol. 2018 11 01; 315(5):F1236-F1242. PMID: 30066583.
      View in: PubMed
    5. Bergsland KJ, Coe FL, Parks JH, Asplin JR, Worcester EM. Evidence for a role of PDZ domain-containing proteins to mediate hypophosphatemia in calcium stone formers. Nephrol Dial Transplant. 2018 05 01; 33(5):759-770. PMID: 29126251.
      View in: PubMed
    6. Worcester EM, Bergsland KJ, Gillen DL, Coe FL. Mechanism for higher urine pH in normal women compared with men. Am J Physiol Renal Physiol. 2018 04 01; 314(4):F623-F629. PMID: 29357436.
      View in: PubMed
    7. Williams JC, Borofsky MS, Bledsoe SB, Evan AP, Coe FL, Worcester EM, Lingeman JE. Papillary Ductal Plugging is a Mechanism for Early Stone Retention in Brushite Stone Disease. J Urol. 2018 01; 199(1):186-192. PMID: 28822796.
      View in: PubMed
    8. Cohen AJ, Borofsky MS, Anderson BB, Dauw CA, Gillen DL, Gerber GS, Worcester EM, Coe FL, Lingeman JE. Endoscopic Evidence That Randall's Plaque is Associated with Surface Erosion of the Renal Papilla. J Endourol. 2017 01; 31(1):85-90. PMID: 27824271.
      View in: PubMed
    9. Williams JC, Worcester E, Lingeman JE. What can the microstructure of stones tell us? Urolithiasis. 2017 Feb; 45(1):19-25. PMID: 27913855.
      View in: PubMed
    10. Coe FL, Worcester EM, Evan AP. Idiopathic hypercalciuria and formation of calcium renal stones. Nat Rev Nephrol. 2016 09; 12(9):519-33. PMID: 27452364.
      View in: PubMed
    11. Witzmann FA, Evan AP, Coe FL, Worcester EM, Lingeman JE, Williams JC. Label-free proteomic methodology for the analysis of human kidney stone matrix composition. Proteome Sci. 2016; 14:4. PMID: 26924944.
      View in: PubMed
    12. Ennis J, Gillen D, Rubenstein A, Worcester E, Brecher ME, Asplin J, Coe F. Clinical decision support improves physician guideline adherence for laboratory monitoring of chronic kidney disease: a matched cohort study. BMC Nephrol. 2015 Oct 15; 16:163. PMID: 26471846.
      View in: PubMed
    13. Borofsky MS, Paonessa JE, Evan AP, Williams JC, Coe FL, Worcester EM, Lingeman JE. A Proposed Grading System to Standardize the Description of Renal Papillary Appearance at the Time of Endoscopy in Patients with Nephrolithiasis. J Endourol. 2016 Jan; 30(1):122-7. PMID: 26414908.
      View in: PubMed
    14. Zisman AL, Evan AP, Coe FL, Worcester EM. Do kidney stone formers have a kidney disease? Kidney Int. 2015 Dec; 88(6):1240-1249. PMID: 26376133.
      View in: PubMed
    15. Bhojani N, Paonessa JE, Hameed TA, Worcester EM, Evan AP, Coe FL, Borofsky MS, Lingeman JE. Nephrocalcinosis in Calcium Stone Formers Who Do Not have Systemic Disease. J Urol. 2015 Nov; 194(5):1308-12. PMID: 25988516.
      View in: PubMed
    16. Ko B, Bergsland K, Gillen DL, Evan AP, Clark DL, Baylock J, Coe FL, Worcester EM. Sex differences in proximal and distal nephron function contribute to the mechanism of idiopathic hypercalcuria in calcium stone formers. Am J Physiol Regul Integr Comp Physiol. 2015 Jul 01; 309(1):R85-92. PMID: 25947170.
      View in: PubMed
    17. Ennis JL, Worcester EM, Coe FL, Sprague SM. Current recommended 25-hydroxyvitamin D targets for chronic kidney disease management may be too low. J Nephrol. 2016 Feb; 29(1):63-70. PMID: 25736620.
      View in: PubMed
    18. Evan AP, Worcester EM, Williams JC, Sommer AJ, Lingeman JE, Phillips CL, Coe FL. Biopsy proven medullary sponge kidney: clinical findings, histopathology, and role of osteogenesis in stone and plaque formation. Anat Rec (Hoboken). 2015 May; 298(5):865-77. PMID: 25615853.
      View in: PubMed
    19. Evan AP, Coe FL, Connors BA, Handa RK, Lingeman JE, Worcester EM. Mechanism by which shock wave lithotripsy can promote formation of human calcium phosphate stones. Am J Physiol Renal Physiol. 2015 Apr 15; 308(8):F938-49. PMID: 25656372.
      View in: PubMed
    20. Taksande SR, Worcester EM. Calcium supplementation in chronic kidney disease. Expert Opin Drug Saf. 2014 Sep; 13(9):1175-85. PMID: 25134623.
      View in: PubMed
    21. Evan AP, Worcester EM, Coe FL, Williams J, Lingeman JE. Mechanisms of human kidney stone formation. Urolithiasis. 2015 Jan; 43 Suppl 1:19-32. PMID: 25108546.
      View in: PubMed
    22. Williams JC, Lingeman JE, Coe FL, Worcester EM, Evan AP. Micro-CT imaging of Randall's plaques. Urolithiasis. 2015 Jan; 43 Suppl 1:13-7. PMID: 25096802.
      View in: PubMed
    23. Evan AP, Lingeman JE, Worcester EM, Sommer AJ, Phillips CL, Williams JC, Coe FL. Contrasting histopathology and crystal deposits in kidneys of idiopathic stone formers who produce hydroxy apatite, brushite, or calcium oxalate stones. Anat Rec (Hoboken). 2014 Apr; 297(4):731-48. PMID: 24478243.
      View in: PubMed
    24. Worcester EM, Evan AP, Coe FL, Lingeman JE, Krambeck A, Sommers A, Phillips CL, Milliner D. A test of the hypothesis that oxalate secretion produces proximal tubule crystallization in primary hyperoxaluria type I. Am J Physiol Renal Physiol. 2013 Dec 01; 305(11):F1574-84. PMID: 24089413.
      View in: PubMed
    25. Worcester EM, Bergsland KJ, Gillen DL, Coe FL. Evidence for increased renal tubule and parathyroid gland sensitivity to serum calcium in human idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Sep 15; 305(6):F853-60. PMID: 23863465.
      View in: PubMed
    26. Bergsland KJ, Worcester EM, Coe FL. Role of proximal tubule in the hypocalciuric response to thiazide of patients with idiopathic hypercalciuria. Am J Physiol Renal Physiol. 2013 Aug 15; 305(4):F592-9. PMID: 23720347.
      View in: PubMed
    27. Xu H, Zisman AL, Coe FL, Worcester EM. Kidney stones: an update on current pharmacological management and future directions. Expert Opin Pharmacother. 2013 Mar; 14(4):435-47. PMID: 23438422.
      View in: PubMed
    28. Ennis J, Worcester E, Coe F. Contribution of calcium, phosphorus and 25-hydroxyvitamin D to the excessive severity of secondary hyperparathyroidism in African-Americans with CKD. Nephrol Dial Transplant. 2012 Jul; 27(7):2847-53. PMID: 22505656.
      View in: PubMed
    29. Coe FL, Evan A, Worcester E. Pathophysiology-based treatment of idiopathic calcium kidney stones. Clin J Am Soc Nephrol. 2011 Aug; 6(8):2083-92. PMID: 21825103.
      View in: PubMed
    30. Bergsland KJ, Zisman AL, Asplin JR, Worcester EM, Coe FL. Evidence for net renal tubule oxalate secretion in patients with calcium kidney stones. Am J Physiol Renal Physiol. 2011 Feb; 300(2):F311-8. PMID: 21123489.
      View in: PubMed
    31. Evan AP, Weinman EJ, Wu XR, Lingeman JE, Worcester EM, Coe FL. Comparison of the pathology of interstitial plaque in human ICSF stone patients to NHERF-1 and THP-null mice. Urol Res. 2010 Dec; 38(6):439-52. PMID: 21063698.
      View in: PubMed
    32. Worcester EM, Coe FL. Clinical practice. Calcium kidney stones. N Engl J Med. 2010 Sep 02; 363(10):954-63. PMID: 20818905.
      View in: PubMed
    33. Koyner JL, Vaidya VS, Bennett MR, Ma Q, Worcester E, Akhter SA, Raman J, Jeevanandam V, O'Connor MF, Devarajan P, Bonventre JV, Murray PT. Urinary biomarkers in the clinical prognosis and early detection of acute kidney injury. Clin J Am Soc Nephrol. 2010 Dec; 5(12):2154-65. PMID: 20798258.
      View in: PubMed
    34. Worcester EM, Coe FL. Evidence for altered renal tubule function in idiopathic calcium stone formers. Urol Res. 2010 Aug; 38(4):263-9. PMID: 20632168.
      View in: PubMed
    35. Coe FL, Evan AP, Lingeman JE, Worcester EM. Plaque and deposits in nine human stone diseases. Urol Res. 2010 Aug; 38(4):239-47. PMID: 20625890.
      View in: PubMed
    36. Evan AP, Lingeman JE, Worcester EM, Bledsoe SB, Sommer AJ, Williams JC, Krambeck AE, Philips CL, Coe FL. Renal histopathology and crystal deposits in patients with small bowel resection and calcium oxalate stone disease. Kidney Int. 2010 Aug; 78(3):310-7. PMID: 20428098.
      View in: PubMed
    37. Coe FL, Evan AP, Worcester EM, Lingeman JE. Three pathways for human kidney stone formation. Urol Res. 2010 Jun; 38(3):147-60. PMID: 20411383.
      View in: PubMed
    38. Evan AP, Lingeman JE, Coe FL, Bledsoe SB, Sommer AJ, Williams JC, Krambeck AE, Worcester EM. Intra-tubular deposits, urine and stone composition are divergent in patients with ileostomy. Kidney Int. 2009 Nov; 76(10):1081-8. PMID: 19710630.
      View in: PubMed
    39. Bergsland KJ, Coe FL, Gillen DL, Worcester EM. A test of the hypothesis that the collecting duct calcium-sensing receptor limits rise of urine calcium molarity in hypercalciuric calcium kidney stone formers. Am J Physiol Renal Physiol. 2009 Oct; 297(4):F1017-23. PMID: 19640901.
      View in: PubMed
    40. Worcester EM, Coe FL. Does idiopathic hypercalciuria trigger calcium-sensing receptor-mediated protection from urinary supersaturation? J Am Soc Nephrol. 2009 Aug; 20(8):1657-9. PMID: 19578005.
      View in: PubMed
    41. Miller NL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Handa SE, Lingeman JE. In idiopathic calcium oxalate stone-formers, unattached stones show evidence of having originated as attached stones on Randall's plaque. BJU Int. 2010 Jan; 105(2):242-5. PMID: 19549258.
      View in: PubMed
    42. Ennis J, Kocherginsky M, Schumm LP, Worcester E, Coe FL, Josephson MA. Trends in kidney donation among kidney stone formers: a survey of US transplant centers. Am J Nephrol. 2009; 30(1):12-8. PMID: 19169005.
      View in: PubMed
    43. Miller NL, Gillen DL, Williams JC, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Matlaga BR, Munch LC, Lingeman JE. A formal test of the hypothesis that idiopathic calcium oxalate stones grow on Randall's plaque. BJU Int. 2009 Apr; 103(7):966-71. PMID: 19021625.
      View in: PubMed
    44. Parks JH, Coe FL, Evan AP, Worcester EM. Clinical and laboratory characteristics of calcium stone-formers with and without primary hyperparathyroidism. BJU Int. 2009 Mar; 103(5):670-8. PMID: 18793297.
      View in: PubMed
    45. Worcester EM, Coe FL, Evan AP, Bergsland KJ, Parks JH, Willis LR, Clark DL, Gillen DL. Evidence for increased postprandial distal nephron calcium delivery in hypercalciuric stone-forming patients. Am J Physiol Renal Physiol. 2008 Nov; 295(5):F1286-94. PMID: 18715937.
      View in: PubMed
    46. Parks JH, Coe FL, Evan AP, Worcester EM. Urine pH in renal calcium stone formers who do and do not increase stone phosphate content with time. Nephrol Dial Transplant. 2009 Jan; 24(1):130-6. PMID: 18662977.
      View in: PubMed
    47. Koyner JL, Bennett MR, Worcester EM, Ma Q, Raman J, Jeevanandam V, Kasza KE, O'Connor MF, Konczal DJ, Trevino S, Devarajan P, Murray PT. Urinary cystatin C as an early biomarker of acute kidney injury following adult cardiothoracic surgery. Kidney Int. 2008 Oct; 74(8):1059-69. PMID: 18650797.
      View in: PubMed
    48. Worcester EM, Coe FL. Nephrolithiasis. Prim Care. 2008 Jun; 35(2):369-91, vii. PMID: 18486720.
      View in: PubMed
    49. Evan AE, Lingeman JE, Coe FL, Miller NL, Bledsoe SB, Sommer AJ, Williams JC, Shao Y, Worcester EM. Histopathology and surgical anatomy of patients with primary hyperparathyroidism and calcium phosphate stones. Kidney Int. 2008 Jul; 74(2):223-9. PMID: 18449170.
      View in: PubMed
    50. Worcester EM, Coe FL. New insights into the pathogenesis of idiopathic hypercalciuria. Semin Nephrol. 2008 Mar; 28(2):120-32. PMID: 18359393.
      View in: PubMed
    51. Evan AP, Coe FL, Gillen D, Lingeman JE, Bledsoe S, Worcester EM. Renal intratubular crystals and hyaluronan staining occur in stone formers with bypass surgery but not with idiopathic calcium oxalate stones. Anat Rec (Hoboken). 2008 Mar; 291(3):325-34. PMID: 18286613.
      View in: PubMed
    52. Evan AP, Lingeman JE, Coe FL, Worcester EM. Role of interstitial apatite plaque in the pathogenesis of the common calcium oxalate stone. Semin Nephrol. 2008 Mar; 28(2):111-9. PMID: 18359392.
      View in: PubMed
    53. Evan AP, Coe FL, Lingeman JE, Shao Y, Sommer AJ, Bledsoe SB, Anderson JC, Worcester EM. Mechanism of formation of human calcium oxalate renal stones on Randall's plaque. Anat Rec (Hoboken). 2007 Oct; 290(10):1315-23. PMID: 17724713.
      View in: PubMed
    54. Evan AP, Bledsoe S, Worcester EM, Coe FL, Lingeman JE, Bergsland KJ. Renal inter-alpha-trypsin inhibitor heavy chain 3 increases in calcium oxalate stone-forming patients. Kidney Int. 2007 Dec; 72(12):1503-11. PMID: 17898697.
      View in: PubMed
    55. Stankus N, Hammes M, Gillen D, Worcester E. African American ESRD patients have a high pre-dialysis prevalence of kidney stones compared to NHANES III. Urol Res. 2007 Apr; 35(2):83-7. PMID: 17310350.
      View in: PubMed
    56. Evan AP, Lingeman J, Coe F, Shao Y, Miller N, Matlaga B, Phillips C, Sommer A, Worcester E. Renal histopathology of stone-forming patients with distal renal tubular acidosis. Kidney Int. 2007 Apr; 71(8):795-801. PMID: 17264873.
      View in: PubMed
    57. Worcester EM, Gillen DL, Evan AP, Parks JH, Wright K, Trumbore L, Nakagawa Y, Coe FL. Evidence that postprandial reduction of renal calcium reabsorption mediates hypercalciuria of patients with calcium nephrolithiasis. Am J Physiol Renal Physiol. 2007 Jan; 292(1):F66-75. PMID: 17210796.
      View in: PubMed
    58. Worcester E, Evan A, Bledsoe S, Lyon M, Chuang M, Orvieto M, Gerber G, Coe F. Pathophysiological correlates of two unique renal tubule lesions in rats with intestinal resection. Am J Physiol Renal Physiol. 2006 Nov; 291(5):F1061-9. PMID: 17028259.
      View in: PubMed
    59. Worcester EM, Parks JH, Evan AP, Coe FL. Renal function in patients with nephrolithiasis. J Urol. 2006 Aug; 176(2):600-3; discussion 603. PMID: 16813897.
      View in: PubMed
    60. Worcester EM, Coe FL, Evan AP, Parks JH. Reduced renal function and benefits of treatment in cystinuria vs other forms of nephrolithiasis. BJU Int. 2006 Jun; 97(6):1285-90. PMID: 16686727.
      View in: PubMed
    61. Evan AP, Coe FL, Lingeman JE, Shao Y, Matlaga BR, Kim SC, Bledsoe SB, Sommer AJ, Grynpas M, Phillips CL, Worcester EM. Renal crystal deposits and histopathology in patients with cystine stones. Kidney Int. 2006 Jun; 69(12):2227-35. PMID: 16710357.
      View in: PubMed
    62. Matlaga BR, Williams JC, Kim SC, Kuo RL, Evan AP, Bledsoe SB, Coe FL, Worcester EM, Munch LC, Lingeman JE. Endoscopic evidence of calculus attachment to Randall's plaque. J Urol. 2006 May; 175(5):1720-4; discussion 1724. PMID: 16600740.
      View in: PubMed
    63. Evan A, Lingeman J, Coe FL, Worcester E. Randall's plaque: pathogenesis and role in calcium oxalate nephrolithiasis. Kidney Int. 2006 Apr; 69(8):1313-8. PMID: 16614720.
      View in: PubMed
    64. Stankus N, Worcester E, Hammes M, Coe FL. Evidence against a contribution of conventional urine risk factors to de novo ESRD renal stones. Nephrol Dial Transplant. 2006 Mar; 21(3):701-6. PMID: 16326738.
      View in: PubMed
    65. Worcester EM, Chuang M, Laven B, Orvieto M, Coe FL, Evan AP, Gerber GS. A new animal model of hyperoxaluria and nephrolithiasis in rats with small bowel resection. Urol Res. 2005 Nov; 33(5):380-2. PMID: 16284881.
      View in: PubMed
    66. Coe FL, Evan A, Worcester E. Kidney stone disease. J Clin Invest. 2005 Oct; 115(10):2598-608. PMID: 16200192.
      View in: PubMed
    67. Evan AP, Coe FL, Lingeman JE, Worcester E. Insights on the pathology of kidney stone formation. Urol Res. 2005 Nov; 33(5):383-9. PMID: 16078085.
      View in: PubMed
    68. Gillen DL, Coe FL, Worcester EM. Nephrolithiasis and increased blood pressure among females with high body mass index. Am J Kidney Dis. 2005 Aug; 46(2):263-9. PMID: 16112044.
      View in: PubMed
    69. Evan AP, Coe FL, Rittling SR, Bledsoe SM, Shao Y, Lingeman JE, Worcester EM. Apatite plaque particles in inner medulla of kidneys of calcium oxalate stone formers: osteopontin localization. Kidney Int. 2005 Jul; 68(1):145-54. PMID: 15954903.
      View in: PubMed
    70. O'Connor RC, Worcester EM, Evan AP, Meehan S, Kuznetsov D, Laven B, Sommer AJ, Bledsoe SB, Parks JH, Coe FL, Grynpas M, Gerber GS. Nephrolithiasis and nephrocalcinosis in rats with small bowel resection. Urol Res. 2005 May; 33(2):105-15. PMID: 15815943.
      View in: PubMed
    71. Gillen DL, Worcester EM, Coe FL. Decreased renal function among adults with a history of nephrolithiasis: a study of NHANES III. Kidney Int. 2005 Feb; 67(2):685-90. PMID: 15673317.
      View in: PubMed
    72. Evan AP, Lingeman JE, Coe FL, Shao Y, Parks JH, Bledsoe SB, Phillips CL, Bonsib S, Worcester EM, Sommer AJ, Kim SC, Tinmouth WW, Grynpas M. Crystal-associated nephropathy in patients with brushite nephrolithiasis. Kidney Int. 2005 Feb; 67(2):576-91. PMID: 15673305.
      View in: PubMed
    73. Parks JH, Worcester EM, Coe FL, Evan AP, Lingeman JE. Clinical implications of abundant calcium phosphate in routinely analyzed kidney stones. Kidney Int. 2004 Aug; 66(2):777-85. PMID: 15253733.
      View in: PubMed
    74. Khan MW, Worcester EM, Straus FH, Khan S, Staszak V, Kaplan EL. Parathyroid carcinoma in secondary and tertiary hyperparathyroidism. J Am Coll Surg. 2004 Aug; 199(2):312-9. PMID: 15275889.
      View in: PubMed
    75. Worcester E, Parks JH, Josephson MA, Thisted RA, Coe FL. Causes and consequences of kidney loss in patients with nephrolithiasis. Kidney Int. 2003 Dec; 64(6):2204-13. PMID: 14633144.
      View in: PubMed
    76. Parks JH, Worcester EM, O'Connor RC, Coe FL. Urine stone risk factors in nephrolithiasis patients with and without bowel disease. Kidney Int. 2003 Jan; 63(1):255-65. PMID: 12472791.
      View in: PubMed
    77. Worcester EM. Stones from bowel disease. Endocrinol Metab Clin North Am. 2002 Dec; 31(4):979-99. PMID: 12474641.
      View in: PubMed
    78. Beshensky AM, Wesson JA, Worcester EM, Sorokina EJ, Snyder CJ, Kleinman JG. Effects of urinary macromolecules on hydroxyapatite crystal formation. J Am Soc Nephrol. 2001 Oct; 12(10):2108-16. PMID: 11562409.
      View in: PubMed
    79. Wesson JA, Worcester EM, Kleinman JG. Role of anionic proteins in kidney stone formation: interaction between model anionic polypeptides and calcium oxalate crystals. J Urol. 2000 Apr; 163(4):1343-8. PMID: 10737541.
      View in: PubMed
    80. Wesson JA, Worcester EM, Wiessner JH, Mandel NS, Kleinman JG. Control of calcium oxalate crystal structure and cell adherence by urinary macromolecules. Kidney Int. 1998 Apr; 53(4):952-7. PMID: 9551403.
      View in: PubMed
    81. Worcester EM. Inhibitors of stone formation. Semin Nephrol. 1996 Sep; 16(5):474-86. PMID: 8890402.
      View in: PubMed
    82. Wesson JA, Worcester E. Formation of hydrated calcium oxalates in the presence of poly-L-aspartic acid. Scanning Microsc. 1996; 10(2):415-23; 423-4. PMID: 9813620.
      View in: PubMed
    83. Lemann J, Pleuss JA, Worcester EM, Hornick L, Schrab D, Hoffmann RG. Urinary oxalate excretion increases with body size and decreases with increasing dietary calcium intake among healthy adults. Kidney Int. 1996 Jan; 49(1):200-8. PMID: 8770968.
      View in: PubMed
    84. Kleinman JG, Beshensky A, Worcester EM, Brown D. Expression of osteopontin, a urinary inhibitor of stone mineral crystal growth, in rat kidney. Kidney Int. 1995 Jun; 47(6):1585-96. PMID: 7643527.
      View in: PubMed
    85. Worcester EM, Kleinman JG, Beshensky AM. Osteopontin production by cultured kidney cells. Ann N Y Acad Sci. 1995 Apr 21; 760:266-78. PMID: 7785901.
      View in: PubMed
    86. Worcester EM, Beshensky AM. Osteopontin inhibits nucleation of calcium oxalate crystals. Ann N Y Acad Sci. 1995 Apr 21; 760:375-7. PMID: 7785921.
      View in: PubMed
    87. Kleinman JG, Worcester EM, Beshensky AM, Sheridan AM, Bonventre JV, Brown D. Upregulation of osteopontin expression by ischemia in rat kidney. Ann N Y Acad Sci. 1995 Apr 21; 760:321-3. PMID: 7785909.
      View in: PubMed
    88. Worcester EM. Urinary calcium oxalate crystal growth inhibitors. J Am Soc Nephrol. 1994 Nov; 5(5 Suppl 1):S46-53. PMID: 7873744.
      View in: PubMed
    89. Worcester EM, Fellner SK, Nakagawa Y, Coe FL. Effect of renal transplantation on serum oxalate and urinary oxalate excretion. Nephron. 1994; 67(4):414-8. PMID: 7969673.
      View in: PubMed
    90. Worcester EM, Sebastian JL, Hiatt JG, Beshensky AM, Sadowski JA. The effect of warfarin on urine calcium oxalate crystal growth inhibition and urinary excretion of calcium and nephrocalcin. Calcif Tissue Int. 1993 Oct; 53(4):242-8. PMID: 8275352.
      View in: PubMed
    91. Worcester EM, Blumenthal SS, Beshensky AM, Lewand DL. The calcium oxalate crystal growth inhibitor protein produced by mouse kidney cortical cells in culture is osteopontin. J Bone Miner Res. 1992 Sep; 7(9):1029-36. PMID: 1414495.
      View in: PubMed
    92. Lemann J, Worcester EM, Gray RW. Hypercalciuria and stones. Am J Kidney Dis. 1991 Apr; 17(4):386-91. PMID: 2008904.
      View in: PubMed
    93. Worcester EM, Nakagawa Y, Wabner CL, Kumar S, Coe FL. Crystal adsorption and growth slowing by nephrocalcin, albumin, and Tamm-Horsfall protein. Am J Physiol. 1988 Dec; 255(6 Pt 2):F1197-205. PMID: 3202183.
      View in: PubMed
    94. Worcester EM, Nakagawa Y, Coe FL. Glycoprotein calcium oxalate crystal growth inhibitor in urine. Miner Electrolyte Metab. 1987; 13(4):267-72. PMID: 3306319.
      View in: PubMed
    95. Worcester EM, Nakagawa Y, Bushinsky DA, Coe FL. Evidence that serum calcium oxalate supersaturation is a consequence of oxalate retention in patients with chronic renal failure. J Clin Invest. 1986 Jun; 77(6):1888-96. PMID: 3711339.
      View in: PubMed
    Worcester's Networks
    Click the "See All" links for more information and interactive visualizations!
    Concepts Expand Description
    _
    Co-Authors Expand Description
    _
    Similar People Expand Description
    _
    Same Department Expand Description
    Physical Neighbors Expand Description
    _